(Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 5.99%112.49B | 5.51%56.38B | 22.15%213.96B | 22.88%160.38B | 22.32%106.14B | 18.25%53.43B | -20.46%175.16B | -27.44%130.52B | -35.88%86.77B | -30.92%45.19B |
Operating income | 5.99%112.49B | 5.51%56.38B | 22.15%213.96B | 22.88%160.38B | 22.32%106.14B | 18.25%53.43B | -20.46%175.16B | -27.44%130.52B | -35.88%86.77B | -30.92%45.19B |
Operating expenses | -2.14%-88.02B | -1.09%-43.91B | -17.24%-168.84B | -17.97%-127.94B | -20.72%-86.18B | -17.50%-43.44B | 19.29%-144.01B | 25.69%-108.45B | 35.21%-71.39B | 30.02%-36.97B |
Gross profit | 22.62%24.47B | 24.75%12.47B | 44.85%45.12B | 46.96%32.44B | 29.73%19.95B | 21.63%9.99B | -25.45%31.15B | -34.97%22.07B | -38.81%15.38B | -34.69%8.22B |
Selling expenses | -10.88%-6.13B | -14.15%-3.27B | -25.78%-13.41B | -22.77%-9.59B | -10.24%-5.53B | -6.39%-2.87B | 7.21%-10.66B | 17.88%-7.81B | 25.38%-5.01B | 21.40%-2.69B |
Administrative expenses | -10.17%-5.09B | -13.80%-2.61B | -16.86%-9.46B | -18.74%-6.99B | -19.21%-4.62B | -14.39%-2.3B | 6.65%-8.09B | 10.47%-5.88B | 14.85%-3.88B | 10.12%-2.01B |
Research and development expenses | -15.60%-4.3B | -14.06%-2.09B | -4.06%-8.04B | -2.47%-5.65B | -0.85%-3.72B | 5.52%-1.83B | -5.72%-7.73B | -2.35%-5.51B | 3.04%-3.69B | -12.24%-1.94B |
Profit from asset sales | 133.12%149.41M | 537.15%133.5M | 128.40%97.05M | 238.47%112.52M | 182.75%64.09M | 184.69%20.95M | -63.74%42.49M | -68.96%33.24M | -73.33%22.67M | -40.34%7.36M |
Revaluation surplus | 226.60%105.69M | -34.74%-30.32M | -135.89%-362.69M | -84.88%148.75M | -93.63%32.36M | -129.26%-22.5M | 157.07%1.01B | 448.21%983.61M | 430.70%507.85M | -42.76%76.92M |
-Changes in the fair value of other assets | 226.60%105.69M | -34.74%-30.32M | -135.89%-362.69M | -84.88%148.75M | -93.63%32.36M | -129.26%-22.5M | 157.07%1.01B | 448.21%983.61M | 430.70%507.85M | -42.76%76.92M |
Impairment and provision | -34.71%-746.88M | -34.74%-453.9M | -15.40%-1.49B | -3.51%-949.49M | 13.40%-554.46M | -34.38%-336.89M | -3.17%-1.29B | -82.41%-917.26M | -149.70%-640.26M | -3.28%-250.69M |
-Other impairment is provision | -34.71%-746.88M | -34.74%-453.9M | -15.40%-1.49B | -3.51%-949.49M | 13.40%-554.46M | -34.38%-336.89M | -3.17%-1.29B | -82.41%-917.26M | -149.70%-640.26M | -3.28%-250.69M |
Special items of operating profit | 183.93%908.35M | 230.97%305.36M | 79.97%1.76B | 61.13%922.68M | -15.15%319.92M | -49.09%92.26M | -10.77%978.69M | -19.96%572.62M | -32.69%377.02M | -18.41%181.22M |
Operating profit | 60.15%8.99B | 60.60%4.22B | 173.38%13.47B | 208.66%9.92B | 97.25%5.61B | 75.45%2.63B | -64.38%4.93B | -73.96%3.21B | -71.57%2.84B | -70.34%1.5B |
Financing cost | -47.92%-31.05M | -104.23%-105.98M | -161.66%-560.25M | -188.75%-526.42M | -103.99%-20.99M | -127.75%-51.89M | 97.27%908.56M | 48.94%593.15M | 171.34%526.36M | 87.81%186.97M |
Special items of earning before tax | -124.34%-38.38M | -14.29%65.82M | -2.05%246.04M | 69.79%241.48M | 196.48%157.68M | 336.75%76.79M | 47.34%251.17M | -9.05%142.23M | -40.71%53.19M | -55.58%17.58M |
Earning before tax | 55.14%8.92B | 57.58%4.18B | 116.12%13.15B | 143.99%9.64B | 67.85%5.75B | 55.82%2.65B | -57.92%6.09B | -69.37%3.95B | -66.72%3.42B | -67.20%1.7B |
Tax | -60.35%-1.54B | -105.30%-832.09M | -381.89%-1.94B | -666.97%-1.64B | -106.87%-961.9M | -50.23%-405.3M | 82.31%-402.52M | 90.38%-213.97M | 72.83%-464.99M | 66.81%-269.78M |
After-tax profit from continuing operations | 54.09%7.37B | 48.96%3.34B | 97.29%11.21B | 114.04%8B | 61.72%4.79B | 56.87%2.25B | -53.36%5.68B | -65.00%3.74B | -65.50%2.96B | -67.27%1.43B |
Earning after tax | 54.09%7.37B | 48.96%3.34B | 97.29%11.21B | 114.04%8B | 61.72%4.79B | 56.87%2.25B | -53.36%5.68B | -65.00%3.74B | -65.50%2.96B | -67.27%1.43B |
Minority profit | 65.88%1.47B | 91.32%745.03M | 182.60%2.2B | 252.53%1.5B | 56.06%886.39M | 18.53%389.42M | -71.11%777.68M | -83.76%424.44M | -72.53%567.98M | -67.90%328.55M |
Profit attributable to shareholders | 51.41%5.9B | 40.07%2.6B | 83.77%9.01B | 96.29%6.5B | 63.07%3.9B | 68.29%1.86B | -48.33%4.91B | -58.91%3.31B | -63.27%2.39B | -67.07%1.1B |
Basic earnings per share | 51.11%0.68 | 42.86%0.3 | 82.46%1.04 | 97.37%0.75 | 66.67%0.45 | 61.54%0.21 | -49.56%0.57 | -60.82%0.38 | -66.67%0.27 | -69.05%0.13 |
Diluted earnings per share | 51.11%0.68 | 42.86%0.3 | 82.46%1.04 | 97.37%0.75 | 66.67%0.45 | 61.54%0.21 | -49.56%0.57 | -60.82%0.38 | -66.67%0.27 | -69.05%0.13 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Auditor | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data